tiprankstipranks
Advertisement
Advertisement

Croda CEO Exercises Share Awards and Sells Shares to Cover Tax

Story Highlights
  • Croda CEO Stephen Foots exercised 2023 performance and deferred bonus share awards at nil cost.
  • He sold 3,622 Croda shares at £26.057 each to cover tax liabilities, with no impact on strategy.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Croda CEO Exercises Share Awards and Sells Shares to Cover Tax

Meet Samuel – Your Personal Investing Prophet

Croda International ( (GB:CRDA) ) just unveiled an announcement.

Croda International chief executive Stephen Foots has exercised conditional share awards granted in March 2023 under the company’s Performance Share Plan and Deferred Bonus Share Plan. The awards covered 1,500 and 6,178 ordinary shares respectively, both at nil cost.

To meet associated tax liabilities, Foots sold a total of 3,622 shares on 17 March at £26.057 each on the London Stock Exchange. The transaction underscores ongoing use of equity-based remuneration for senior management but does not signal any change in Croda’s underlying operations or strategic direction.

The most recent analyst rating on (GB:CRDA) stock is a Buy with a £2917.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.

Spark’s Take on CRDA Stock

According to Spark, TipRanks’ AI Analyst, CRDA is a Neutral.

The score reflects solid financial stability (manageable leverage and positive cash generation) and supportive technical momentum, balanced against a demanding valuation (high P/E) and execution risk highlighted on the earnings call (exceptional charges and segment volatility despite improving guidance and transformation progress).

To see Spark’s full report on CRDA stock, click here.

More about Croda International

Croda International Plc is a specialty chemicals company that develops and supplies high-performance ingredients and technologies to sectors including consumer care, life sciences and industrial markets. The group focuses on innovative, sustainable chemistries used in products such as personal care formulations, crop protection and other advanced materials for global customers.

Average Trading Volume: 560,821

Technical Sentiment Signal: Strong Sell

Current Market Cap: £3.7B

See more insights into CRDA stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1